A series of experiments was performed to prepare acidic macroencapsulated buffers composed of 20% Ca(H2PO4)(2) and 80% Eudragit S 100 polymer and alkaline macrocapsules composed of 65% K2HPO4 and 35% Eudragit E PO polymer (the powdered form of Eudragit E 100). Eudragit S 100 was shown to be soluble at a pH greater than 7.0, while Eudragit E 100 was soluble at a pH less than 7.0. Both polymers did not impart significant biochemical oxygen demand. The Eudragit E PO polymer solution showed low toxicity (EC50=91%) based on the Microtox Acute Toxicity Test compared to the 0.1mM background phosphate buffer solution (EC50=100%) while the Eudragit S 100 polymer solution showed higher toxicity (EC50=53%). Batch tests showed that the acidic macrocapsules reduced the pH of a 0.1mM phosphate solution from 11 to neutral, while the alkaline macrocapsules increased the pH of a 0.1mM phosphate solution from 3 to neutral. The macrocapsules could potentially be used as an in situ proportional pH controller for groundwater remediation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.chemosphere.2007.07.060 | DOI Listing |
PLoS One
January 2025
Faculty of Pharmacy, Sardar Bahadur Khan Women University Quetta, Quetta, Pakistan.
Controlled-release microparticles offer a promising avenue for enhancing patient compliance and minimizing dosage frequency. In this study, we aimed to design controlled-release microparticles of Glipizide utilizing Eudragit S100 and Methocel K 100 M polymers as controlling agents. The microparticles were fabricated through a simple solvent evaporation method, employing various drug-to-polymer ratios to formulate different controlled-release batches labeled as F1 to F5.
View Article and Find Full Text PDFJ Biomater Sci Polym Ed
December 2024
Department of Pharmaceutics, Dr. Prabhakar B Kore Basic Science Research Center, Off-campus, KLE College of Pharmacy (A constituent unit of KAHER-Belagavi), Bengaluru, Karnataka, India.
Zaltoprofen (ZAL) is a non-steroidal anti-inflammatory drug (NSAID) with a short half-life (∼2.8 h) due to extensive first pass metabolism. In this context, 16 different polymeric film forming solutions (PFFS) of ZAL were developed using different grades of Eudragits, Polyvinylpyrrolidones, Kollicoat MAE 100 P and Hydroxypropyl cellulose as film formers, and polyethylene glycol 400 as a plasticizer in equal parts of ethanol and isopropyl alcohol used as solvents.
View Article and Find Full Text PDFRecent Adv Drug Deliv Formul
December 2024
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo 11884, Egypt.
Background: Norfloxacin (NFX) is a wide-spectrum antibacterial agent that suffers from low water solubility and first-pass metabolism. This diminishes its oral bioavailability by 60-70%.
Objective: This work aims to formulate a topical gel of NFX-loaded lipid polymer hybrid nanoparticles (NFX-LPHNPs) that combine the merits of liposomes and polymeric nanoparticles to overcome these problems.
Assay Drug Dev Technol
January 2025
Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, Taif, Kingdom of Saudi Arabia.
Pharmaceutics
October 2024
Pharmacology and Pharmacometric Laboratory, LABFAR, Federal University of Pampa (UNIPAMPA), Uruguaiana 97501-970, RS, Brazil.
: Investigating how nanoparticle systems interact in whole blood (WB) is critical to evaluating the effectiveness of malaria therapy. Methods: We decided to establish a pharmacokinetic/pharmacodynamic (PK/PD) model of the quinine population in WB using -infected mice, with a subsequent model comparison for nanocapsules coated with polysorbate (NCP80) or prepared with Eudragit RS (NCEUD). The WB quinine population pharmacokinetic model in rats was developed using plasma and partition coefficients for rat erythrocytes.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!